ProNAi Therapeutics (DNAI) Tops Q4 EPS by 20c
Tweet
Share
E-mailGet Alerts DNAI Hot Sheet
Join SI Premium – FREE
ProNAi Therapeutics (NASDAQ: DNAI) reported Q4 EPS of ($0.38), $0.20 better than the analyst estimate of ($0.58).
For earnings history and earnings-related data on ProNAi Therapeutics (DNAI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Omega Flex (OFLX) Tops Q2 EPS by 27c
- Boxlight Corporation (BOXL) Tops Q2 EPS by 2050c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
